AI-Driven Mortality Risk Analysis: How Sea Point Generates Alpha

The life settlement market has historically relied on third-party Life Expectancy (LE) reports from actuarial underwriters to price policies. While these reports provide valuable mortality estimates, they often exhibit systematic biases and fail to capture the full complexity of medical data. This creates pricing inefficiencies that sophisticated buyers can exploit.

At Sea Point Capital, we've built a proprietary AI system that reviews independent LE reports alongside redacted medical records to form our own mortality view. This technology enables us to identify mispriced policies where the market's longevity assumptions diverge from our data-driven analysis.

How Our AI System Works

Our underwriting process combines three key components:

•AI Medical Underwriter: Our proprietary system processes redacted medical records and actuarial tables to generate an independent life expectancy assessment
•Comparative Analysis: We systematically compare our AI-generated LE against third-party "market" LE reports to identify discrepancies
•Bidding Strategy Agent: Our AI reviewing agent synthesizes these inputs to produce a disciplined bid/no-bid decision

Our AI system is designed to produce bid decisions on fewer than 10% of policies reviewed. This disciplined approach ensures we only acquire assets with superior risk-adjusted return potential.

Discovering Value Through Data

By systematically analyzing medical data, our AI identifies patterns that human underwriters may overlook or weight inconsistently. This includes subtle interactions between diagnoses, treatment histories, and demographic factors that affect mortality outcomes.

When our AI mortality view differs meaningfully from market pricing, we have an opportunity to acquire policies at attractive valuations. For example, if the market prices a policy based on a 48-month LE but our analysis suggests 36 months, the policy may be significantly undervalued relative to its expected returns.

Conversely, when our AI indicates longer-than-expected lifespans, we pass on policies that others might overpay for. This two-way edge—both identifying undervalued policies and avoiding overvalued ones—is the foundation of our alpha generation.

Structural Alpha in an Uncorrelated Strategy

What makes this approach particularly compelling is the combination of AI-driven alpha with zero beta exposure. Unlike traditional alternative strategies that claim to be "market neutral" but retain some correlation to equity or credit markets, life insurance assets are genuinely uncorrelated. Mortality outcomes don't change when the S&P 500 falls or interest rates rise.

This means our AI advantage translates directly into portfolio returns without the confounding effects of market beta. We're not simply harvesting risk premia available to any buyer—we're generating true alpha through superior information processing and disciplined execution.

Continuous Learning and Model Evolution

As our portfolio matures and policies reach their mortality events, we observe realized outcomes and incorporate this feedback into our models. This creates a virtuous cycle: better predictions lead to better policy selection, which generates more data for model refinement.

While we don't disclose the specifics of our model architecture or training data (both are proprietary), we can share that our approach leverages modern machine learning techniques including ensemble methods, feature engineering from medical text, and Bayesian calibration.

Our competitive edge comes from years of accumulated training data, domain expertise, and continuous model iteration. This is not a commodity technology that competitors can easily replicate.

Investment Precision at Scale

AI doesn't replace human judgment at Sea Point—it augments it. Our investment committee reviews all AI recommendations and applies additional qualitative factors including carrier quality, policy structure, servicing complexity, and portfolio fit.

However, by systematically processing large volumes of medical data and LE reports, our AI enables us to evaluate far more opportunities than would be possible through manual underwriting alone. This scale advantage means we see more flow, identify more mispriced policies, and construct better-diversified portfolios.

The result is a repeatable, scalable source of alpha that we believe will continue to generate superior risk-adjusted returns as we grow the strategy.

Conclusion

AI-driven underwriting represents a fundamental shift in how life settlement portfolios are constructed. By combining proprietary technology with deep domain expertise, Sea Point has built a durable competitive moat in an asset class that remains institutionally underserved.

For qualified investors seeking uncorrelated returns with a structural alpha component, our approach offers a compelling value proposition. We invite accredited investors to request our full investment materials to learn more about how we're applying AI to generate superior outcomes in life insurance assets.